A Randomized, Open-Label Phase II Trial of Volasertib as...

  • Main
  • 2015 / 6
  • A Randomized, Open-Label Phase II Trial of Volasertib as...
Clinical Lung Cancer 2015 / 6

A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non–Small-Cell Lung Cancer

Ellis, Peter M., Leighl, Natasha B., Hirsh, Vera, Reaume, M. Neil, Blais, Normand, Wierzbicki, Rafal, Sadrolhefazi, Behbood, Gu, Yu, Liu, Dan, Pilz, Korinna, Chu, Quincy
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2015.05.010
Date:
June, 2015
File:
PDF, 761 KB
english, 2015
Conversion to is in progress
Conversion to is failed